HWAM
Hennion & Walsh Asset Management’s Immunovant IMVT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-143,080
| Closed | -$5.49M | – | 837 |
|
|
2023
Q3 | $5.49M | Sell |
143,080
-28,248
| -16% | -$1.08M | 0.35% | 51 |
|
|
2023
Q2 | $3.25M | Sell |
171,328
-56,228
| -25% | -$1.07M | 0.19% | 131 |
|
|
2023
Q1 | $3.53M | Sell |
227,556
-26,080
| -10% | -$404K | 0.22% | 120 |
|
|
2022
Q4 | $4.5M | Buy |
253,636
+23,961
| +10% | +$425K | 0.28% | 88 |
|
|
2022
Q3 | $1.28M | Sell |
229,675
-6,322
| -3% | -$35.3K | 0.08% | 271 |
|
|
2022
Q2 | $920K | Buy |
235,997
+14,861
| +7% | +$57.9K | 0.06% | 331 |
|
|
2022
Q1 | $1.22M | Buy |
221,136
+60,336
| +38% | +$332K | 0.06% | 299 |
|
|
2021
Q4 | $1.37M | Buy |
160,800
+94,658
| +143% | +$806K | 0.07% | 294 |
|
|
2021
Q3 | $575K | Buy |
66,142
+22,642
| +52% | +$197K | 0.03% | 477 |
|
|
2021
Q2 | $460K | Buy |
+43,500
| New | +$460K | 0.02% | 540 |
|